FAPCX
Price
$18.73
Change
+$0.07 (+0.38%)
Updated
Jun 6 closing price
Net Assets
1.86B
RERHX
Price
$60.37
Change
+$0.19 (+0.32%)
Updated
Jun 6 closing price
Net Assets
133.45B
Interact to see
Advertisement

FAPCX vs RERHX

Header iconFAPCX vs RERHX Comparison
Open Charts FAPCX vs RERHXBanner chart's image
Fidelity Intl Cptl Apprec K6
Price$18.73
Change+$0.07 (+0.38%)
VolumeN/A
Net Assets1.86B
American Funds EUPAC R5E
Price$60.37
Change+$0.19 (+0.32%)
VolumeN/A
Net Assets133.45B
FAPCX vs RERHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FAPCX vs. RERHX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAPCX is a StrongBuy and RERHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERHX has more cash in the bank: 133B vs. FAPCX (1.86B). RERHX pays higher dividends than FAPCX: RERHX (1.24) vs FAPCX (0.90). FAPCX was incepted earlier than RERHX: FAPCX (8 years) vs RERHX (10 years). FAPCX (0.66) is less costly to investors than RERHX (0.62). FAPCX is a more actively managed with annual turnover of: 84.00 vs. RERHX (30.00). FAPCX has a lower initial minimum investment than RERHX: FAPCX (0) vs RERHX (250). FAPCX annual gain was more profitable for investors over the last year : 12.85 vs. RERHX (3.04). FAPCX return over 5 years is better than : 48.76 vs. RERHX (19.49).
FAPCXRERHXFAPCX / RERHX
Total Expense Ratio0.660.62106%
Annual Report Gross Expense Ratio0.660.62106%
Fund Existence8 years10 years-
Gain YTD15.82913.371118%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.86B133B1%
Annual Yield % from dividends0.901.2473%
Returns for 1 year12.853.04422%
Returns for 3 years48.4417.47277%
Returns for 5 years48.7619.49250%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCAT8.160.84
+11.48%
Red Cat Holdings
NVCR17.000.55
+3.34%
NovoCure Limited
CVEO22.840.39
+1.74%
Civeo Corp
HALO54.250.70
+1.31%
Halozyme Therapeutics
SE165.61-4.79
-2.81%
Sea Limited